Precursor flat urothelial lesions: Molecular landscape, pathogenesis, and biological insights
- 11 May 2026
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 284, 156517
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insightsVirchows Archiv, 2024
- Use of Artificial Intelligence for the Interpretable Prediction of the Pathologic Diagnosis and Molecular Abnormalities of Flat Urothelial LesionsThe American Journal of Pathology, 2022
- TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancerMolecular Oncology, 2020
- Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary BladderThe American Journal of Pathology, 2020
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2017
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaCancer Cell, 2016
- The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/NeuAnnals of Diagnostic Pathology, 2014
- Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer developmentInternational Journal of Cancer, 2009
- Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetWorld Journal of Urology, 2007
- Flat intraepithelial lesions of the urinary bladderCancer, 2000